Tecnovatica Company Description

Tecnovatica S.A. engages in the building and development of an integrated ecosystem of health services using modern genetics and imaging diagnostics in Poland, the European Union and global markets.

Its areas of activity are NIPT prenatal diagnostics, genetic cancer diagnostics, artificial intelligence in diagnostics, telemedicine and mobile applications, medical marijuana and supportive therapies, and translational medicine and scientific cooperation.

The company was formerly known as Vinci Gen S.A. and changed its name to Tecnovatica S.A. in January 2026.

Tecnovatica S.A. was incorporated in 2010 and is headquartered in Warsaw, Poland.

Tecnovatica S.A.

Country	Poland
Founded	2010
Industry	Biological Products, Except Diagnostic Substances
Employees	1
CEO	Michal Marczuk

Contact Details

Address: ul. Krucza 16/22 Warsaw, 00-526 Poland
Website	tecnovatica.pl

Stock Details

Ticker Symbol	TEC
Exchange	Warsaw Stock Exchange
Fiscal Year	January - December
Reporting Currency	PLN
SIC Code	2836

Key Executives

Name	Position
Michal Marczuk	Chief Executive Officer